| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ace2e2d7bd8f319fe057e809c693bd37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7531197ef36d7110d8c359e9230444b7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-36 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0457 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00 |
| filingDate |
2014-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74fe7161487a4c349da4563ea26ae8e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d309e36f6e655ddcf80ffda741c4c33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e7940ca4a3f187cf157cc878154362d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e38b00983001cbcba03ed3ccc93132a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26a7b7ef924aa3327f540acd7c9f8b11 |
| publicationDate |
2014-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014377187-A1 |
| titleOfInvention |
Embolizing Sclerosing Hydrogel |
| abstract |
A sclerosing embolizing hydrogel comprising from about 0.1% by weight to about 4.0% by weight of chitosan; from about 0.01 M to about 1 M of hydrochloric acid; from 0% by volume to about 40% by volume of iopamidol; from 0.5% by weight to about 25% by weight of β-glycerophosphate disodium salt; and from about 0.05% by weight to about 4% by weight of sodium tetradecyl sulphate. Also a kit for synthesizing the hydrogel and a method using the hydrogel to treat a vascular defect in a subject. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11685007-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109843192-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11633818-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11717924-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11679458-B2 |
| priorityDate |
2010-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |